NCT03654768 2025-12-18Testing the Addition of Ruxolitinib to the Usual Treatment (Tyrosine Kinase Inhibitors) for Chronic Myeloid LeukemiaSWOG Cancer Research NetworkPhase 2 Active not recruiting81 enrolled 20 charts